E-LIB Suche - Ergebnisse für: Saunders, Robert N.

1

Surrogate-based model chains for establishing process-struc..:

Ye, Jiahui ; Saunders, Robert N. ; Elwany, Alaa
Manufacturing Letters. 35 (2023) - p. 750-759 , 2023

Link: https://doi.org/10.1016/..

2

Metal AM process-structure-property relational linkages usi..:

Saunders, Robert N. ; Teferra, Kirubel ; Elwany, Alaa..
Additive Manufacturing. 62 (2023) - p. 103398 , 2023

Link: https://doi.org/10.1016/..

3

Towards Identification of Correspondence Rules to Relate Tr..:

Saunders, Robert N. ; Tan, X. Gary ; Qidwai, Siddiq M..
Annals of Biomedical Engineering. 47 (2018) 9 - p. 2005-2018 , 2018

Link: https://doi.org/10.1007/..

4

A simplified model for high-rate actuation of shape memory ..:

Saunders, Robert N ; Boyd, James G ; Hartl, Darren J..
Journal of Intelligent Material Systems and Structures. 29 (2017) 6 - p. 1088-1101 , 2017

Link: https://doi.org/10.1177/..

5

Inhibition by SRI 63-072 and SRI 63-119 of PAF-acether and ..:

Handley, Dean A. ; Anderson, Robert C. ; Saunders, Robert N.
European Journal of Pharmacology. 141 (1987) 3 - p. 409-416 , 1987

Link: https://doi.org/10.1016/..

6

Biological properties of the antagonist SRI 63–441 in the P..:

Handley, Dean A. ; Van Valen, Ronald G. ; Tomesch, John C....
Immunopharmacology. 13 (1987) 2 - p. 125-132 , 1987

Link: https://doi.org/10.1016/..

7

Vascular responses of platelet-activating factor in the Ceb..:

Handley, Dean A. ; Van Valen, Ronald G. ; Saunders, Robert N.
Immunopharmacology. 11 (1986) 3 - p. 175-182 , 1986

Link: https://doi.org/10.1016/..

8

Evidence for distinct systemic extravasation effects of pla..:

Handley, Dean A. ; Farley, Constance ; Deacon, Richard W..
Prostaglandins, Leukotrienes and Medicine. 21 (1986) 3 - p. 269-277 , 1986

Link: https://doi.org/10.1016/..

9

Platelet activating factor and inflammation in atherogenesi..:

Handley, Dean A. ; Saunders, Robert N.
Drug Development Research. 7 (1986) 4 - p. 361-375 , 1986

Link: https://doi.org/10.1002/..

10

Inhibition and reversal of endotoxin-, aggregated IgG- and ..:

Handley, Dean A. ; Van Valen, Ronald G. ; Melden, Mary K....
Immunopharmacology. 12 (1986) 1 - p. 11-16 , 1986

Link: https://doi.org/10.1016/..

11

Inhibition of platelet activating factor: Synthesis and bio..:

Lee, Mark L. ; Winslow, Christine M. ; Jaeggi, Christian...
Prostaglandins. 30 (1985) 4 - p. 690 , 1985

Link: https://doi.org/10.1016/..

12

Effect of platelet activating factor on endothelial permeab..:

Handley, Dean A. ; Arbeeny, Cynthia M. ; Lee, Mark L...
Immunopharmacology. 8 (1984) 3-4 - p. 137-142 , 1984

Link: https://doi.org/10.1016/..

13

Antiplatelet activity of hydralazine:

Burns, Thomas S. ; Saunders, Robert N.
Thrombosis Research. 16 (1979) 5-6 - p. 837-842 , 1979

Link: https://doi.org/10.1016/..

14

Quantitation of in vivo platelet aggregation by the platele..:

Burns, Thomas S ; Saunders, Robert N
Thrombosis Research. 10 (1977) 4 - p. 629-633 , 1977

Link: https://doi.org/10.1016/..

15

Effects of SC-26096 [2-methyl-3-oxo-2-azabicyclo (2.2.2.) o..:

Mackerer, Carl R. ; Haettinger, Janet R. ; Saunders, Robert N...
Biochemical Pharmacology. 23 (1974) 10 - p. 1531-1543 , 1974

Link: https://doi.org/10.1016/..